Trilipix™ (fenofibric acid) Capsule, Delayed Release For Oral Use is indicated as adjunct to diet as combination therapy with statins for patients with mixed dyslipidemia or as monotherpy for patients with severe hypertriglyceridemia, primary hyperlipidemia or mixed dyslipidemia. Recommended initial dose: 45mg to 135mg once daily. Recommended daily dose range: 45mg to 135mg once daily. Active Ingredients: fenofibric acid.